The association between CD47 protein expression and clinical characteristics in biopsy tissues, along with the enhanced phagocytic activity towards osteosarcoma cells by the CD47 antibody, suggests the potential value of CD47 in osteosarcoma immunotherapy. The gene discussed is CD47; the disease is osteosarcoma.